Meanwhile, the BSE Sensex was down 334.20 points, or 1.98% to 16,542.86.
On BSE, 2.48 lakh shares were traded in the counter as against average daily volume of 97,853 shares in the past two weeks.
The stock hit a high of Rs 279.45 and a low of Rs 256.10 so far during the day.
Also Read
Natco Pharma today, 8 December 2011, announced the closure of a qualified institutional placement (QIP). The issue opened on Wednesday, 7 December 2011, and was closed on the same day. The company said it is in the process of allocating 30 lakh shares to the eligible qualified institutional buyers. The company said it is raising Rs 67.50 crore through this issue, primarily to part-finance its expansion plans. The announcement was made during trading hours today, 8 December 2011.
On a consolidated basis, Natco Pharma's net profit rose 7.6% to Rs 15.94 crore on 4% growth in net sales to Rs 124.84 crore in Q2 September 2011 over Q2 September 2010.
Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app